For patients with severe obesity (BMI 40 kg/m or 35 kg/m with comorbidities) who have not achieved adequate weight loss with lifestyle and pharmacological interventions, bariatric surgery may be considered
Eli Lilly, the pharmaceutical company behind retatrutide, declined to comment on the protocols of its ongoing trials but stated that patient safety is a priority
Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: a systematic review and meta-analysis
It does not indicate a problem with the peptide
The headline finding: clinical rigor is high, but the experience is padded with marketing interstitials and the multi-month plan billing model is loaded into the final checkout step
Insulin resistance is associated with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD), polycystic ovary syndrome (PCOS), obstructive sleep apnea, and certain metabolic-related conditions